H-Index & Metrics Top Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Medicine H-index 201 Citations 233,613 1,283 World Ranking 58 National Ranking 8

Research.com Recognitions

Awards & Achievements

2008 - Fellow of the Royal Society of Edinburgh

Fellow of The Academy of Medical Sciences, United Kingdom

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Heart failure
  • Cardiology

John J.V. McMurray mostly deals with Internal medicine, Heart failure, Cardiology, Ejection fraction and Heart disease. His work in Internal medicine tackles topics such as Endocrinology which are related to areas like Gastroenterology. His Heart failure research is multidisciplinary, incorporating perspectives in Epidemiology, Diabetes mellitus, Intensive care medicine and Candesartan, Angiotensin II.

His Intensive care medicine research includes themes of MEDLINE and Public health. His work deals with themes such as Valsartan and Proportional hazards model, which intersect with Cardiology. The study incorporates disciplines such as Irbesartan, Blood pressure, Spironolactone and Cause of death in addition to Ejection fraction.

His most cited work include:

  • 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines (9721 citations)
  • 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. (9345 citations)
  • 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (3899 citations)

What are the main themes of his work throughout his whole career to date?

John J.V. McMurray mainly investigates Internal medicine, Heart failure, Cardiology, Ejection fraction and Myocardial infarction. His studies deal with areas such as Diabetes mellitus and Endocrinology as well as Internal medicine. His biological study spans a wide range of topics, including Clinical trial, Surgery, Intensive care medicine, Placebo and Heart disease.

His work carried out in the field of Intensive care medicine brings together such families of science as Epidemiology and MEDLINE. His studies in Cardiology integrate themes in fields like Stroke and Proportional hazards model. The concepts of his Ejection fraction study are interwoven with issues in Candesartan, Natriuretic peptide, Clinical endpoint and Blood pressure.

He most often published in these fields:

  • Internal medicine (78.12%)
  • Heart failure (71.15%)
  • Cardiology (59.10%)

What were the highlights of his more recent work (between 2017-2021)?

  • Internal medicine (78.12%)
  • Heart failure (71.15%)
  • Cardiology (59.10%)

In recent papers he was focusing on the following fields of study:

John J.V. McMurray focuses on Internal medicine, Heart failure, Cardiology, Ejection fraction and Hazard ratio. His work in Internal medicine addresses issues such as Diabetes mellitus, which are connected to fields such as Kidney disease. His Heart failure study also includes

  • Placebo which connect with Adverse effect,
  • Myocardial infarction that connect with fields like Stroke.

John J.V. McMurray has researched Cardiology in several fields, including Neprilysin, Proportional hazards model, Blood pressure and Clinical endpoint. His Ejection fraction study combines topics in areas such as Omecamtiv mecarbil, Renal function, Eplerenone, Quality of life and Sudden cardiac death. His Hazard ratio research includes elements of Randomized controlled trial and Cohort.

Between 2017 and 2021, his most popular works were:

  • Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction (1150 citations)
  • Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19. (1007 citations)
  • Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial (555 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Heart failure
  • Cardiology

His primary areas of investigation include Internal medicine, Heart failure, Cardiology, Ejection fraction and Diabetes mellitus. His Internal medicine study combines topics from a wide range of disciplines, such as Placebo and Dapagliflozin. His study focuses on the intersection of Heart failure and fields such as Valsartan with connections in the field of Neprilysin.

His Cardiology research incorporates elements of Candesartan, Interquartile range, Proportional hazards model and Renal function. He interconnects Quality of life, Diastole and Omecamtiv mecarbil in the investigation of issues within Ejection fraction. His study in Diabetes mellitus is interdisciplinary in nature, drawing from both Insulin and Kidney disease.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Top Publications

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

Piotr Ponikowski;Adriaan A. Voors;Stefan D. Anker;Héctor Bueno.
European Journal of Heart Failure (2016)

19435 Citations

2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Clyde W. Yancy;Mariell Jessup;Biykem Bozkurt;Javed Butler.
Journal of the American College of Cardiology (2013)

10481 Citations

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Paulus Kirchhof;Stefano Benussi;Dipak Kotecha;Anders Ahlsson.
Europace (2016)

8635 Citations

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

John J.V. McMurray;Stamatis Adamopoulos;Stefan D. Anker;Angelo Auricchio.
European Heart Journal (2012)

7218 Citations

2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Clyde W. Yancy;Mariell Jessup;Biykem Bozkurt;Javed Butler.
Circulation (2013)

4150 Citations

Angiotensin-neprilysin inhibition versus enalapril in heart failure.

John J. V. McMurray;Milton Packer;Akshay S. Desai;Jianjian Gong.
The New England Journal of Medicine (2014)

4135 Citations

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

John Jv McMurray;Jan Östergren;Karl Swedberg;Christopher B Granger.
The Lancet (2003)

3520 Citations

Guidelines on the management of valvular heart disease The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology

Alec Vahanian;Helmut Baumgartner;Jeroen Bax;Eric Butchart.
European Heart Journal (2006)

3367 Citations

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

Salim Yusuf;Marc A Pfeffer;Karl Swedberg;Christopher B Granger.
The Lancet (2003)

3170 Citations

Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both

Marc A. Pfeffer;John J.V. McMurray;Eric J. Velazquez;Jean-Lucien Rouleau.
The New England Journal of Medicine (2003)

3054 Citations

Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking h-index is inferred from publications deemed to belong to the considered discipline.

If you think any of the details on this page are incorrect, let us know.

Contact us

Top Scientists Citing John J.V. McMurray

Gregory Y.H. Lip

Gregory Y.H. Lip

University of Liverpool

Publications: 832

John G.F. Cleland

John G.F. Cleland

National Institutes of Health

Publications: 502

Gregg C. Fonarow

Gregg C. Fonarow

University of California, Los Angeles

Publications: 467

Marco Metra

Marco Metra

University of Brescia

Publications: 414

Javed Butler

Javed Butler

University of Mississippi

Publications: 388

Dirk J. van Veldhuisen

Dirk J. van Veldhuisen

University Medical Center Groningen

Publications: 374

Adriaan A. Voors

Adriaan A. Voors

University Medical Center Groningen

Publications: 348

Piotr Ponikowski

Piotr Ponikowski

Wrocław Medical University

Publications: 346

Gerasimos Filippatos

Gerasimos Filippatos

National and Kapodistrian University of Athens

Publications: 337

Faiez Zannad

Faiez Zannad

University of Lorraine

Publications: 319

Mihai Gheorghiade

Mihai Gheorghiade

Northwestern University

Publications: 301

Adrian F. Hernandez

Adrian F. Hernandez

Duke University

Publications: 280

Scott D. Solomon

Scott D. Solomon

Brigham and Women's Hospital

Publications: 276

Aldo P. Maggioni

Aldo P. Maggioni

Heart Care Foundation, ANMCO Research Center, Florence

Publications: 270

Alexandre Mebazaa

Alexandre Mebazaa

Université Paris Cité

Publications: 268

Something went wrong. Please try again later.